thiazoles has been researched along with Atypical Chronic Myeloid Leukemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verstovsek, S | 1 |
| Chalukya, M; Gondek, L; Jasek, M; Maciejewski, J; Nicoll, J; Paquette, RL; Sawyers, CL; Shah, NP | 1 |
| Billström, R; Ekblom, M; Fioretos, T; Larsson, N; Lassen, C; Lilljebjörn, H; Richter, J | 1 |
| Besra, SE; Bhattacharya, S; Das, M; Ghosh, P; Gomes, A; Majumdar, J; Mitra, S; Murmu, N; Sur, P; Vedasiromoni, JR | 1 |
| Anagnostopoulos, A; Athanasiadou, A; Fassas, A; Gaitatzi, M; Lalayanni, C; Papaioannou, G | 1 |
1 review(s) available for thiazoles and Atypical Chronic Myeloid Leukemia
| Article | Year |
|---|---|
Preclinical and clinical experience with dasatinib in Philadelphia chromosome-negative leukemias and myeloid disorders.
Topics: Antineoplastic Agents; Dasatinib; Humans; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Pyrimidines; Thiazoles | 2009 |
4 other study(ies) available for thiazoles and Atypical Chronic Myeloid Leukemia
| Article | Year |
|---|---|
Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Base Sequence; Bone Marrow Cells; Cell Differentiation; Clone Cells; Cytogenetic Analysis; Dasatinib; Female; Follow-Up Studies; Genes, p53; Hematopoiesis; Humans; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Male; Middle Aged; Molecular Sequence Data; Philadelphia Chromosome; Pyrimidines; Thiazoles; Treatment Outcome | 2010 |
Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells.
Topics: Chromosomes, Human, Pair 7; Dasatinib; Female; Genes, ras; Humans; In Situ Hybridization, Fluorescence; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Middle Aged; Monosomy; Mutation; Myelodysplastic Syndromes; Oligonucleotide Array Sequence Analysis; Polymorphism, Single Nucleotide; Prognosis; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Pyrimidines; ras Proteins; Thiazoles | 2010 |
Antineoplastic effect of new boron compounds against leukemic cell lines and cells from leukemic patients.
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Boron Compounds; Cell Division; Guanidines; HL-60 Cells; Humans; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Tetrazolium Salts; Thiazoles; Thymidine; U937 Cells | 2002 |
Novel chromosomal aberration in Philadelphia negative cells of a patient with chronic myelogenous leukemia treated with dasatinib.
Topics: Adult; Chromosome Aberrations; Dasatinib; Humans; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Male; Pyrimidines; Thiazoles | 2008 |